Close Menu

NEW YORK – IsoPlexis said on Tuesday that it has signed an exclusive agreement with Medquest to distribute IsoPlexis' products in Singapore and Malaysia.

Financial terms of the agreement were not disclosed.

Based in Branford, Connecticut, IsoPlexis markets products for single-cell proteomics research, including the IsoLight System, an automated platform for comprehensive functional protein and metabolite profiling of single cells.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.